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The COVID-19 pandemic, caused by the SARS-CoV-2 virus, emerged in late 2019 and quickly 
spread worldwide, resulting in over 125 million infections and 2.7 million deaths as of March 2021 
accordingly to the World Health Organization. Despite the great advances achieved by the 
scientific community in providing crucial information about this virus, we are still far from 
completely understanding it. 
SARS-CoV-2 is an enveloped virus, meaning that it is encapsulated by a lipid membrane, which 
needs to be fused to the host membrane to begin the infection process. Fusion between viral and 
host membrane is catalyzed by the spike (S) glycoprotein. The S-protein is composed of essential 
elements for the infection mechanism, namely the receptor-binding domain known to bind to 
angiotensin-converting enzyme 2 during the viral entry pathway. Another important region, 
known as the fusion peptide (FP), plays an essential part in the fusion mechanism, by inserting 
into and disturbing the host membrane. There is still not a consensus among scientists in terms 
of the fusion peptide location on the S-protein sequence, with two major candidate regions 
having been proposed. 
We recently used a machine learning-based tool developed by us to identify viral FPs with 
accuracies over 85%. With this tool a putative FP, previously suggested in the literature, has been 
identified, as well as other proposals including the requirement of more than one FP. To further 
address this question, we are performing a systematic analysis of the SARS-CoV-2 putative FPs, 
using Molecular Dynamics (MD) simulations, which provide a detailed perspective of how these 
peptides insert and interact with the membrane. In parallel, we are characterizing these systems 
experimentally. Additionally we are exploring therapeutic strategies targeting these regions. 
Given the major role of the FP in the virus infection process, this work provides relevant insights 
and contributes to the fight against COVID-19. 
  
